Next Article in Journal
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
Next Article in Special Issue
The Role of Extracellular Vesicles in Melanoma Progression
Previous Article in Journal
Clinical Benefits of Indocyanine Green Fluorescence in Robot-Assisted Partial Nephrectomy
Previous Article in Special Issue
Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma
 
 
Review

Article Versions Notes

Cancers 2022, 14(12), 3030; https://doi.org/10.3390/cancers14123030
Action Date Notes Link
article xml file uploaded 20 June 2022 16:00 CEST Original file -
article xml uploaded. 20 June 2022 16:00 CEST Update https://www.mdpi.com/2072-6694/14/12/3030/xml
article pdf uploaded. 20 June 2022 16:00 CEST Version of Record https://www.mdpi.com/2072-6694/14/12/3030/pdf
article html file updated 20 June 2022 16:01 CEST Original file -
article html file updated 12 August 2022 21:28 CEST Update https://www.mdpi.com/2072-6694/14/12/3030/html
Back to TopTop